Skip to content

Effects of Prone Position After Major Abdominal Surgery

Effects of Prone Position After Major Abdominal Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05630443
Acronym
EPOS
Enrollment
200
Registered
2022-11-29
Start date
2022-10-01
Completion date
2026-12-31
Last updated
2024-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications, Postoperative, Lung Infection, Surgery

Keywords

complications postoperative, lungcomplications, abdominal surgery, prone position

Brief summary

Evaluation of postoperative prone position after major abdominal surgery. A randomized clinical trial of 100+100 patients and further add a voice/speech/singing protocol.

Detailed description

Evaluation of postoperative prone position after major abdominal surgery. A randomized clinical trial of 100+100 patients and further add a voice/speech/singing protocol. The patients will be randomized to the standard ERAS-protocol, enhanced recovery after surgery with or without adding periods of prone position after surgery. They will be followed by protocol both as a momentum effect (experimental study) on POD 2-5 and also POD 7. The aim is evaluation of prone position in order to improve the ventilation and hopefully diminish the risk of for example pneumonia and thromboembolism. Inclusion criteria Patients referred to the Department of Surgery for major abdominal surgery of the esophagus, gastric- or pancreas surgery aim to cure. Exclusion criteria Patients unable to understand Swedish in writing or speaking, preoperatively unable to perform a prone position. The participation is voluntary and demands an inform consent from the patient operated upon. The primary outcome is oxygen saturation and lung complications after surgery. The secondary outcome is measurement of lung volumes, patient experience (7th graded Lickert scale), days of hospital care, 30 days complications etc. Further investigations are perioperative properties as BMI, other forms of surgery, etc., and continues measurement of blood pressure, respiration frequency, heartrate, tubes and drainages, postoperative analgesic, blood samples with signs of bleeding, inflammation, infection.

Interventions

PROCEDUREprone position

Ordinary ERAS treatment postoperatvely adding the prone position and voicetraining

Sponsors

Vastra Gotaland Region
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

prospective randomized controlled study

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Patients eligable for abdominal surgery aim to cure with: Inclusion Criteria: \- malignancy of the esophagus, gastric- or pancreas

Exclusion criteria

-.not able to understand Swedish in writing or speaking \- preoperatively unable to perform a prone position

Design outcomes

Primary

MeasureTime frameDescription
Oxygen saturation measurement postoperativelyan average of (POD) Postoperative day 2-7Measurement during sitting position
Number of participants with treatment-related adverse events of postoperative lung and abdominal complications incl a CT scan for objective measurementthrough study completion, an average of 1 yearAdverse events like pneumonia, lungembolism, lungempyema, interventions pankreatitis
Number of participants with treatment-related adverse events of postoperative lung and abdominal complicationsthrough study completion, an average of 1 yearPneumonia, Lung embolism, Empyema of the lung, pankreatitis

Secondary

MeasureTime frameDescription
Number of participants with treatment-related diminished lung volumesthrough study completion, an average of 1 yearSpirometric measurements of diminished lung volumes
Number of days of Hospital carethrough study completion, an average of 1 yearDays of inhouse treatment
Number of participants needing interventionthrough study completion, an average of 1 yearTreament intervention like antibiotics or other medical or interventional treatment

Countries

Sweden

Contacts

Primary ContactCecilia Engstrom Mattisson, MD PhD
cecilia.engstrom.@surgery.gu.se+46704970393
Backup ContactCecilia Engstrom Mattisson, MD PhD
cecilia.engstrom.mattisson@vgregion.se

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026